Phenolic Compounds as Promising Drug Candidates in Tuberculosis Therapy
Tuberculosis (TB), caused by <i>Mycobacterium tuberculosis</i> (MTB) remains one of the deadliest, infectious diseases worldwide. The detrimental effects caused by the existing anti-TB drugs to TB patients and the emergence of resistance strains of <i>M. tuberculosis</i> has...
Main Authors: | Muhamad Harith Mazlun, Siti Fatimah Sabran, Maryati Mohamed, Mohd Fadzelly Abu Bakar, Zunoliza Abdullah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/13/2449 |
Similar Items
-
A review of medicinal plant of Middle East and North Africa (MENA) region as source in tuberculosis drug discovery
by: Ali Sami Dehyab, et al.
Published: (2020-09-01) -
Ethnobotany, ethnopharmacology, and phytochemistry of traditional medicinal plants used in the management of symptoms of tuberculosis in East Africa: a systematic review
by: Samuel Baker Obakiro, et al.
Published: (2020-08-01) -
Silver Nanoparticles for the Therapy of Tuberculosis
by: Tăbăran AF, et al.
Published: (2020-03-01) -
Design, synthesis and biological evaluation of verapamil analogues, reversed isoniazids and hybrid efflux pump inhibitors against Mycobacterium tuberculosis
by: Kumar, Malkeet
Published: (2016) -
Anti-Mycobacterium tuberculosis activity of fungus Phomopsis stipata
by: Karina Andrade de Prince, et al.
Published: (2012-03-01)